Company news

Journey Medical Corporation news in 2025

Journey Medical Corporation's news releases, calls and decks from 2025, newest first.

View company

Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology

December 11, 2025

Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology

December 10, 2025

Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

November 12, 2025

Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025

November 5, 2025

Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference

October 24, 2025

Journey Medical Corporation to Participate in October 2025 Investor Conferences

October 8, 2025

Journey Medical Corporation to Participate in September 2025 Investor Conferences

September 3, 2025

Journey Medical Corporation to Present at the Emerging Growth Conference

August 18, 2025

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

August 12, 2025

Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11

August 7, 2025

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025

August 5, 2025

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™

July 14, 2025

Journey Medical to Join Russell 2000® and Russell 3000® Indexes

June 24, 2025

Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference

June 20, 2025

Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV

June 9, 2025

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 14, 2025

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025

May 7, 2025

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

April 1, 2025

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

March 26, 2025

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

March 24, 2025

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

March 19, 2025

Journey Medical Corporation to Participate in the 37th Annual ROTH Conference

March 12, 2025

Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea

March 5, 2025

Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida

March 4, 2025

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

January 22, 2025

Calls in 2025

Decks in 2025